
Alithea Genomics
Backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | N/A | Debt | |
Total Funding | 000k |
Related Content
Alithea Genomics is a biotechnology startup that operates in the field of RNA sequencing. The company's primary offering is its multiplexed RNA seq solutions, which are designed to simplify and streamline the generation of large amounts of RNA data. This data is crucial for the discovery of new biomarkers and the development of new drugs. Alithea Genomics' solutions are compatible with a variety of sample types, from purified RNA to cells and organoid lysate, and have been validated on plant RNA samples.
The company's business model is service-based. Clients send their samples to Alithea Genomics, which then processes them using its RNA sequencing technologies. The processed samples are then returned to the clients in the form of raw sequencing data. This service allows clients to conduct large-scale RNA sequencing experiments in a cost-effective and timely manner.
Alithea Genomics primarily serves clients in the research and medical fields. These clients use the company's services to conduct their own research or to develop new drugs. By providing a cost-effective and efficient solution for RNA sequencing, Alithea Genomics is able to help its clients make significant advancements in their respective fields.
In summary, Alithea Genomics is a biotech startup that provides RNA sequencing services. The company's solutions are designed to simplify the generation of large amounts of RNA data, which is crucial for the discovery of new biomarkers and the development of new drugs. Alithea Genomics serves clients in the research and medical fields and operates on a service-based business model.
Keywords: RNA sequencing, biomarkers, drug development, research, medical, service-based business model, cost-effective, efficient, biotechnology, genomics.